Supplied byUWA Biotech
Supplier locationUnited States
Dispatch1–2 business days
VerificationReport available
Public report information
Review the testing reference and connected report information before viewing the supplier listing.
Research product overview
Product details supplied through the connected marketplace listing.
Product overview
Retatrutide is a next-generation investigational peptide supplied by UWA Biotech for laboratory studies involving metabolic regulation, peptide signalling pathways and advanced research applications. This listing is available in wholesale box configurations with multiple vial strengths.
Available formats
- 10 × 20mg (200mg total)
- 10 × 30mg (300mg total)
- MOQ: 10 vials / 1 box
- Supplier: UWA Biotech
Verification
- Purity: 99.692%–99.808%
- Tested: 08 JAN 2026
- Task number: #97490
- Unique key: I1X2VVFWT3UM
Supply details
- Supplier: UWA Biotech
- Location: United States
- Formats: 20mg and 30mg options
- Packaging: Wholesale 10-vial boxes
This product is supplied exclusively for laboratory research use. Not for human consumption, medical treatment or clinical application.
This listing is provided for laboratory and research sourcing review. It is not intended for human consumption, medical use or self-administration.